Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports,
Erlangen, 91052, Germany
NCT Number: NCT03306069
The main purpose of this study is to compare the impact of aerobic interval training intensity on exercise adherence and changes in cardiorespiratory fitness, cardiometabolic risk profile, body composition, inflammatory markers and subjective health outcomes after a 12-week intervention trial in overweight individuals at increased cardiometabolic risk.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Erlangen, 91052, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Individualized, weight-reducing nutritional therapy and counseling, during a study period of 12 weeks
Procedures: Nutritional therapy (individualized, weightreducing nutritional therapy and counseling) during a study period of 12 weeks combined with supervised ergometer-based high-intensity interval training (HIIT).
HIIT:
Procedures: Nutritional therapy (individualized, weightreducing nutritional therapy and counseling) during a study period of 12 weeks combined with supervised ergometer-based moderate-intensity interval training on the basis of HRmax (MIIT-HR).
MIIT-HR:
Procedures: Nutritional therapy (individualized, weightreducing nutritional therapy and counseling) during a study period of 12 weeks combined with supervised ergometer-based moderate-intensity interval training on the basis of lactate threshold (MIIT-LT).
MIIT-LT:
Time frame: 12 weeks (baseline to 12 week follow-up assessment)
CRF will be assessed by measuring Maximum Oxygen uptake (VO2max)
Time frame: 12 weeks (baseline to 12 week follow-up assessment)
MetS-Z-Score will be calculated from each individual's measures of waist circumference, mean arterial blood pressure, triglycerides, and HDL-cholesterol, based on equations specific to sex.
Time frame: 12 weeks (baseline to 12 week follow-up assessment)
Muscle mass, fat mass and body water will be measured by Bioelectrical Impedance Analysis (BIA)
Time frame: 12 weeks (baseline to 12 week follow-up assessment)
Insulin sensitivity will be estimated using homeostasis model assessment index (HOMA)
Time frame: 12 weeks (baseline to 12 week follow-up assessment)
Inflammation will be assessed by measuring levels of inflammatory blood markers
Time frame: 12 weeks (baseline to 12 week follow-up assessment)
Health-related quality of life will be assessed by using the standardized and validated EQ-5D-5L Questionnaire
Time frame: 12 weeks (baseline to 12 week follow-up assessment)
Pain scores will be assessed by using the standardized and validated Chronic Pain Grade Questionnaire (CPGQ)
Time frame: 12 weeks (baseline to 12 week follow-up assessment)
Perceived stress will be assessed by using the standardized and validated Perceived Stress Questionnaire (PSQ)
Time frame: 12 weeks (baseline to 12 week follow-up assessment)
Subjective work ability will be assessed by using the standardized and validated Work Ability Index Questionnaire (WAI)
University of Erlangen-Nürnberg Medical School
Other
Low-volume Aerobic Interval Training in Overweight Individuals at Increased Cardiometabolic Risk: Impact of Training Intensity on Cardiorespiratory Fitness, Cardiometabolic Risk Profile and Exercise Adherence
Acronym: BELITA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05730231
Antioxidative Stress, Behavior
Izola, Slovenia
View Trial DetailsNCT07431593
Body Weight, Glucose Metabolism Disorders
Varaždin, Croatia
View Trial DetailsNCT06018415
Behavior, Body Weight
Xi'an, Shaanxi, China
View Trial DetailsNCT04519164
Body Weight, Cardiovascular Diseases
Boston, Massachusetts, United States
View Trial Details